| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.514 | 4.077 | 7.475 | 8.841 | 9.383 | 6.938 | 6.230 | 8.432 | 7.730 | 5.727 |
| Total Income - EUR | 1.514 | 4.077 | 7.475 | 8.841 | 9.383 | 6.959 | 6.230 | 8.432 | 9.622 | 5.832 |
| Total Expenses - EUR | 2.425 | 4.326 | 5.602 | 4.789 | 4.790 | 5.151 | 8.278 | 7.072 | 9.188 | 7.402 |
| Gross Profit/Loss - EUR | -911 | -249 | 1.873 | 4.052 | 4.592 | 1.808 | -2.048 | 1.360 | 434 | -1.570 |
| Net Profit/Loss - EUR | -957 | -371 | 1.649 | 3.787 | 4.311 | 1.675 | -2.148 | 1.107 | 186 | -1.570 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - European M.d. Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 895 | 739 | 1.603 |
| Current Assets | 464 | 969 | 2.957 | 3.720 | 4.737 | 6.420 | 1.106 | 771 | 6.495 | 767 |
| Inventories | 0 | 0 | 0 | 82 | 0 | 7 | 0 | 0 | 0 | 0 |
| Receivables | 401 | 111 | 110 | 141 | 82 | 50 | 0 | 33 | 33 | 420 |
| Cash | 63 | 857 | 2.847 | 3.497 | 4.654 | 6.363 | 1.106 | 737 | 6.462 | 347 |
| Shareholders Funds | -4.945 | -5.266 | -3.528 | 323 | 4.628 | 1.724 | -2.099 | -998 | -809 | -2.375 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.410 | 6.234 | 6.485 | 3.396 | 109 | 4.696 | 3.206 | 2.664 | 8.043 | 4.744 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - European M.d. Company Srl